A Novel Reconstruction Device for Osteonecrotic Femoral Head Efficacy Evaluation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Skeletally matured between age 20 to 70 (epiphyses of the femoral head are confirmed to be closed on the radiography, CT, or MRI scan
- Patients without any allergies or major systemic or organ diseases
- Patient's affected hip diagnossied as the 3rd stage of ONFH by MRI
Exclusion Criteria:
- Other lower lib fractures
- Pregnancy
- Extensive degenerative arthritis in hip
- Severe osteoporosis in the head and/or neck of the femoral bone
- Rheumatoid immunity or metabolic arthritis that appears to have severe cartilage damage in the hip
- Stiffness in the hip due to other reasons or medical history with its range of motion clinically measures less than 20 degrees in the abduction and less than 90 degrees flexion
- Diagnosed with either Stage 4, 5, or 6, of ONFH classification by either radiography, MR, CT scan.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Osteonecrotic Repair Device
A biphasic osteochrondral composite method to support the regeneration of articular cartilage in vivo.
With its concept that could be securely installed by press-fit without additional fixation, this approach can present an alternative to perform graft harvest and implantation in a single surgery.
|
10 patients will be randomized chosen in this group
|
|
ACTIVE_COMPARATOR: Core Decompression
Core decompression is a common surgical procedure that aims to improve vascular inflow by decreasing intraosseous pressure in the femoral head.
It is performed that involves removing a cylindrical core of bone from the proximal femur.
|
10 patients will be randomized chosen in this group
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Western Ontario and McMAster Universities Osteoartheitis Index (WOMAC)
Time Frame: Baseline before procedure/surgery up to follow up 2 years after
|
Questionaire Scoring
|
Baseline before procedure/surgery up to follow up 2 years after
|
|
Visual Analogue Scale(VAS)
Time Frame: Baseline before procedure/surgery up to follow up 2 years after
|
Subjective Pain Scoring
|
Baseline before procedure/surgery up to follow up 2 years after
|
|
Harris Hip Score (HHS)
Time Frame: Baseline before procedure/surgery up to follow up 2 years after
|
Scoring
|
Baseline before procedure/surgery up to follow up 2 years after
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 201111037DIB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.